Evidence map›Paper›PMID 20543849›Full record

ArticleNature genetics2010

Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity.

Suzanne M Noble, Sarah French, Lisa A Kohn, Victoria Chen, Alexander D Johnson

Abstract read
In one paragraph

Article in Nature genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 456 papers.

0numbers the graph read from it
0cells of the map it votes in
456citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

456 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. The power of many: when genetics met yeasts and high-throughput.Biological reviews of the Cambridge Philosophical Society · 2026
    Review
  6. The unique Efg1 fungal virulence regulon in the catheterized bladder environment.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Review
  8. Profound cell wall remodeling inMicrobiology spectrum · 2026
    Article
  9. Article
  10. EditingBiomolecules · 2026
    Review
  11. Article
  12. Article
  13. A roadmap to chemically reactive species: how diverse oxidants affectMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  14. Article
  15. ThemBio · 2025
    Article
  16. An optimized protocol forbioRxiv : the preprint server for biology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article

396 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Suzanne M NobleDepartment of Microbiology and Immunology, University of California San Francisco, San Francisco, California, USA. suzanne.noble@ucsf.edu
Sarah French
Lisa A Kohn
Victoria Chen
Alexander D Johnson

Funding

A Genetic Approach to Virulence in C. albicansK08AI062800 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NOBLE, SUZANNE M · 2005 to 2007
$328k
Howard Hughes Medical InstituteNIAID NIH HHS K08 AI062800PHS HHS R01 A149187
6 · The paper itself

Abstract

Candida albicans is the most common cause of serious fungal disease in humans. Creation of isogenic null mutants of this diploid organism, which requires sequential gene targeting, allows dissection of virulence mechanisms. Published analyses of such mutants show a near-perfect correlation between C. albicans pathogenicity and the ability to undergo a yeast-to-hypha morphological switch in vitro. However, most studies have used mutants constructed with a marker that is itself a virulence determinant and therefore complicates their interpretation. Using alternative markers, we created approximately 3,000 homozygous deletion strains affecting 674 genes, or roughly 11% of the C. albicans genome. Screening for infectivity in a mouse model and for morphological switching and cell proliferation in vitro, we identified 115 infectivity-attenuated mutants, of which nearly half demonstrated normal morphological switching and proliferation. Analysis of such mutants revealed that virulence requires the glycolipid glucosylceramide. To our knowledge, this is the first C. albicans small molecule that has been found to be required specifically for virulence.

Indexed as

Gene DeletionGene LibraryAnimalsCandida albicansCandidiasisFemaleFungal ProteinsGlucosylceramidesHomozygoteHumansHyphaeMiceMice, Inbred BALB CMolecular StructureMorphogenesisMutationFungal ProteinsGlucosylceramides

Identifiers

PMID20543849
PMCPMC2893244

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.